Skip to main content
HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.
Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.
Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic Leukemia.
Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-cell acute lymphoblastic leukemia.
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes.
Delayed Recognition and Significant Morbidity in Adults with Non-Transfusion-Dependent Thalassemia.
Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.
Yes, we can omit TBI for ALL!
Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexity.
In Utero Hematopoietic Cell Transplantation in Fetuses with Alpha Thalassemia Major: A Phase 1 Clinical Trial.